Global Microfluidic Devices Market, Share, Size, Trend, Analysis and forecast to 2020

GLOBAL INDUSTRY INSIGHT: Microfluidic Devices Market Development and Demand Forecast to 2020

© P&S Market Research. All rights reserved 2

Global Microfluidic Devices Market Development and Demand Forecast to 2020

P&S Market Research releases a new research report “Global Industry Insight: Microfluidic Devices Market Development and Demand Forecast to 2020” with market overview, trends, DRO analysis, market

segmentation, market size and forecast, porter analysis, recent developments, competitive scenario and top

competitor profiles.

The market of microfluidic devices is gaining significant importance due to growing R&D investment in life

sciences, pharmaceuticals, and increasing point of care testing demand. The global market for microfluidic

devices is expected to grow at a CAGR of 23.0% during the period 2015 to 2020 to reach $6,471 million by 2020.

The factors driving the growth of microfluidic devices market are increase in demand for point of care testing

products, rise in the commercial and analytical applications of these devices and use of microfluidic products for

miniaturization of chip.

Browse report description with detailed TOC: https://www.psmarketresearch.com/market-analysis/microfluidic-

devices-market

Continuous innovations in microfluidic devices have led to transformation of drug discovery and development,

gene expression analysis and genotyping in the pharmaceutical and biopharmaceutical industry. Microfluidic

device companies are entering in collaborations and partnerships to build a more innovative approach, offering

advanced tools for diagnostics and research. But, regulatory issues act as hindrance in the development of

microfluidic devices market. Apart from regulatory challenges, the market also confronts issues from surface

chemistry and geometrical problem during manufacturing process.

On the basis of application, point of care testing (POCT) is by far the fastest growing application area of

microfluidic devices. The application of microfluidic devices in POCT is expected to witness a CAGR of 28.2%

during the period 2015 to 2020 and to reach $1.8 billion in 2020. An increase in point of care testing, as an

effective method for delivery of treatment, has also led to increase in demand for the microfluidic devices in the

global market. Diagnostic companies are getting access to microfluidic based technologies through acquisitions,

as it reduces the technology development risk, and thereby increases the reactivity.

In terms of material, the polymer had the largest share in the global microfluidic devices market, and it is expected

to grow at the highest CAGR among all the materials during the forecast period. Polymer is an attractive

alternative to glass and silicon, as it has faster fabrication process and is comparatively cheaper. Polymer has

also become the most preferred substrate for POCT applications, and has several advantages like oxygen

permeability, gas permeability, nontoxic and optical transparency.

At present North America dominates the global microfluidic devices market, driven by factors such as growing

geriatric population, increasing health and wellness awareness, rising occurrence of chronic and lifestyle ailments,

informed insurance options and various technological developments suited for varied applications. Asia-Pacific is

expected to emerge as an attractive market for companies manufacturing medical devices. In Europe, the

microfluidic devices market is driven by increased diagnostic requirements, attributed to rising diseases and

https://www.psmarketresearch.com/market-analysis/microfluidic-devices-market

https://www.psmarketresearch.com/market-analysis/microfluidic-devices-market



lifestyle changes, aging population and improving healthcare facilities. The European microfluidic devices market

is expected to report the highest CAGR during 2015 to 2020 among all the regions; whereas, North America will

remain the largest market in 2020.

Request for report sample: https://www.psmarketresearch.com/enquiry-

form.php?enqid=211&title=Report%20sample

The major companies operating in the drug of abuse testing market include Abbott Laboratories, Agilent

Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. Cepheid, Dolomite Centre, F.

Hoffmann-La Roche, Fluidigm Corporation, Johnson & Johnson, Micronit Microfluidics, RainDance Technologies,

Inc., and Siemens Healthcare, Inc.

MICROFLUIDIC DEVICES MARKET SEGMENTATION Global Microfluidic Devices Market Breakdown

• By Industry

• By Application

• By Material

• By Region Microfluidic Devices Market Breakdown by Industry

• In-vitro Diagnostics (IVD)

• Pharmaceuticals

• Medical Devices Microfluidic Devices Market Breakdown by Application

• Point of Care Testing

• Pharmaceutical and Life Science Research

• Drug Delivery

• Analytical Devices

• Clinical and Veterinary Diagnostics

• Environmental and Industrial Microfluidic Devices Market Breakdown by Material

• Glass

• Polymer

• Silicon GEOGRAPHICAL SEGMENTATION

https://www.psmarketresearch.com/enquiry-form.php?enqid=211&title=Report%20sample

https://www.psmarketresearch.com/enquiry-form.php?enqid=211&title=Report%20sample



Drug of Abuse Testing Market by Region

• North America

o The U.S.

o Canada

• Europe

o Germany

o France

o Italy

o Spain

o The U.K.

o Belgium

o Netherland

o Switzerland • Asia-Pacific

o Japan

o China

o India

TABLE OF CONTENT

Chapter 1 Research Scope and Methodology

1.1 Market Definition

1.2 Market Breakdown by Industry, Application and Material

1.3 Market Breakdown by Geography

1.4 Research Methodology and Sources

Chapter 2 Executive Summary

2.1 Key Findings

2.2 Research Summary



Chapter 3 Market Outlook

3.1 Introduction

3.2 Trends in the Market

3.2.1 New product innovations

3.2.2 Rise in partnerships and collaborations

3.3 Factors Driving the Market and its Impact on Market Forecast

3.3.1 Material mix changes providing opportunities for new players

3.3.2 Increase in global demand for point of care testing

3.3.3 Microfluidic technologies for miniaturization of chip

3.3.4 Rising demand in genomics and proteomics studies

3.3.5 Impact analysis of drivers on market forecast

3.4 Factors Hindering the Market and its Impact on Market Forecast

3.4.1 Geometrical and surface chemistry issues

3.4.2 Adherence to stringent regulatory requirements

3.4.3 Impact Analysis of Restraints on Market Forecast

Chapter 4 Global Market Size and Forecasts (2011 – 2020)

4.1 Global Market Breakdown by Industry

4.2 Global Market Breakdown by Application

4.3 Global Market Breakdown by Material

4.4 Global Market Breakdown by Region

Chapter 5 Global Market Breakdown by Industry



5.1 In-vitro Diagnostics (IVD) Market Breakdown by Region

5.2 Pharmaceuticals Market Breakdown by Region and by Product

5.3 Medical Devices Market Breakdown by Region and by Product

Chapter 6 Global Market Breakdown by Application

6.1 Point of Care Testing Market Breakdown by Region

6.2 Pharmaceutical and Life Science Research Market Breakdown by Region

6.3 Drug Delivery Market Breakdown by Region

6.4 Analytical Devices Market Breakdown by Region

6.5 Clinical and Veterinary Diagnostics Market Breakdown by Region

6.6 Environmental and Industrial Market Breakdown by Region

Chapter 7 Global Market Breakdown by Material

7.1 Glass Market Breakdown by Region

7.2 Polymer Market Breakdown by Region

7.3 Silicon Market Breakdown by Region

Chapter 8 Global Market Breakdown by Region

8.1 North America Market Breakdown by Country

8.2 Europe Market Breakdown by Country

8.3 Asia-Pacific Market Breakdown by Country

Chapter 9 Competitive Analysis and Market Share

9.1 Porter's Five Forces of Competitive Position Analysis

9.1.1 Bargaining power of buyers



9.1.2 Bargaining power of suppliers

9.1.3 Threat of new entrants

9.1.4 Intensity of rivalry

9.1.5 Threat of substitutes

9.2 Competitive Positioning of Key Competitors

Chapter 10 Company Profiles

10.1 F. Hoffmann-La Roche AG

10.1.1 Business Overview

10.1.2 Products and Services

10.1.3 Recent Developments

10.2 Abbott Laboratories




10.3 Siemens Healthcare GmbH




10.4 Agilent Technologies, Inc.






10.5 Fluidigm Corporation




10.6 Bio-Rad Laboratories, Inc.




10.7 Cepheid




10.8 RainDance Technologies, Inc.




10.9 Dolomite Centre






10.10 Micronit Microfluidics




10.11 Johnson & Johnson




10.12 Becton, Dickinson and Company




Chapter 11 Appendix

11.1 List of Abbreviations

LIST OF FIGURES

FIG. 1 Applications of microfluidic devices

FIG. 2 Global microfluidic devices market share by industry (2014)

FIG. 3 Global microfluidic devices market share by application (2014)

FIG. 4 Global microfluidic devices market share by material (2014)

FIG. 5 Global microfluidic devices market share by region (2014)



FIG. 6 In-vitro diagnostics industry microfluidic devices market share by region (2014)

FIG. 7 Pharmaceutical industry microfluidic devices market share by region (2014)

FIG. 8 Pharmaceutical industry microfluidic devices market share by product (2014)

FIG. 9 Chips for Analytics in microfluidic devices market by product (2014)

FIG. 10 Medical devices industry microfluidic devices market share by region (2014)

FIG. 11 Medical devices industry microfluidic devices market share by product (2014)

FIG. 12 Point of care testing microfluidic devices market share by region (2014)

FIG. 13 Pharmaceutical and life science research microfluidic devices market share by region

(2014)

FIG. 14 Drug delivery microfluidic devices market share by region (2014)

FIG. 15 Analytical devices microfluidic devices market share by region (2014)

FIG. 16 Clinical and veterinary microfluidic devices market share by region (2014)

FIG. 17 Environmental and industrial application microfluidic devices market share by region

(2014)

FIG. 18 Glass microfluidic devices market share by region (2014)

FIG. 19 Polymer microfluidic devices market share by region (2014)

FIG. 20 Silicon microfluidic devices market share by region (2014)

FIG. 21 North America microfluidic devices market share by country (2014)

FIG. 22 Europe microfluidic devices market share by country (2014)

FIG. 23 Asia microfluidic devices market share by country (2014)

FIG. 24 Porter’s five forces of competitive position analysis

FIG. 25 Competitive positioning of key competitors



LIST OF TABLES

TABLE 1 Specific primary and secondary sources used for this publication

TABLE 2 Global microfluidic devices market snapshot (2015 and 2020)

TABLE 3 Products launched by various companies

TABLE 4 Collaborations and partnerships in microfluidic devices market

TABLE 5 Drivers for the market: Impact analysis

TABLE 6 Restraints for the market: Impact analysis

TABLE 7 Global market breakdown by industry, $m (2011 – 2014)

TABLE 8 Global market breakdown by industry, $m (2015 – 2020)

TABLE 9 Global market breakdown by application, $m (2011 – 2014)

TABLE 10 Global market breakdown by application, $m (2015 – 2020)

TABLE 11 Global market breakdown by material, $m (2011 – 2014)

TABLE 12 Global market breakdown by material, $m (2015 – 2020)

TABLE 13 Global market breakdown by region, $m (2011 – 2014)

TABLE 14 Global market breakdown by region, $m (2015 – 2020)

TABLE 15 In-vitro diagnostic microfluidic devices market by region, $m (2011-2014)

TABLE 16 In-vitro diagnostic microfluidic devices market by region, $m (2015-2020)

TABLE 17 Pharmaceutical microfluidic devices market by region, $m (2011-2014)

TABLE 18 Pharmaceutical microfluidic devices market by region, $m (2015-2020)

TABLE 19 Pharmaceutical microfluidic devices market by product, $m (2011-2014)

TABLE 20 Pharmaceutical microfluidic devices market by product, $m (2015-2020)



TABLE 21 Chips for lab analytics microfluidic devices by product, $m (2011-2014)

TABLE 22 Chips for lab analytics microfluidic devices by product, $m (2015-2020)

TABLE 23 Medical device microfluidic devices market by region, $m (2011-2014)

TABLE 24 Medical device microfluidic devices market by region, $m (2015-2020)

TABLE 25 Medical devices industry in microfluidic devices market, by product, $m (2011-2014)

TABLE 26 Medical device microfluidic devices market by product, $m (2015-2020)

TABLE 27 Point of care testing microfluidic devices market by region, $m (2011-2014)

TABLE 28 Point of care testing in microfluidic devices market by region, $m (2015-2020)

TABLE 29 Pharmaceutical and life science research microfluidic device market by region, $m

(2011-2014)

TABLE 30 Pharmaceutical and life science research microfluidic device market by region, $m

(2015-2020)

TABLE 31 Drug delivery microfluidic devices market by region, $m (2011-2014)

TABLE 32 Drug delivery microfluidic devices market by region, $m (2015-2020)

TABLE 33 Analytical device microfluidic devices market by region, $m (2011-2014)

TABLE 34 Analytical device microfluidic devices market by region, $m (2015-2020)

TABLE 35 Clinical and veterinary diagnostics microfluidic devices market by region, $m (2011-

2014)

TABLE 36 Clinical and veterinary diagnostics microfluidic devices market by region, $m (2015-

2020)

TABLE 37 Environmental and industrial microfluidic devices market by region, $m (2011-2014)

TABLE 38 Environmental and industrial microfluidic devices market by region, $m (2015-2020)

TABLE 39 Glass microfluidic devices market by region, $m (2011 – 2014)



TABLE 40 Glass microfluidic devices market by region, $m (2015 – 2020)

TABLE 41 Polymer microfluidic devices market by region, $m (2011 – 2014)

TABLE 42 Polymer microfluidic devices market by region, $m (2015 – 2020)

TABLE 43 Silicon microfluidic devices market by region, $m (2011 – 2014)

TABLE 44 Silicon microfluidic devices market by region, $m (2015 – 2020)

TABLE 45 North America microfluidic devices market by country, $m (2011 – 2014)

TABLE 46 North America microfluidic devices market by country, $m (2015 – 2020)

TABLE 47 Europe microfluidic devices market by country, $m (2011 – 2014)

TABLE 48 Europe microfluidic devices market by country, $m (2015 – 2020)

TABLE 49 Asia-Pacific microfluidic devices market by country, $m (2011 – 2014)

TABLE 50 Asia-Pacific microfluidic devices market by country, $m (2015 – 2020)

TABLE 51 F. Hoffmann-La Roche AG – Key Facts

TABLE 52 Abbott Laboratories – Key Facts

TABLE 53 Siemens Healthcare GmbH– Key Facts

TABLE 54 Agilent Technologies, Inc. – Key Facts

TABLE 55 Fluidigm Corporation – Key Facts

TABLE 56 Bio-Rad Laboratories, Inc. – Key Facts

TABLE 57 Cepheid – Key Facts

TABLE 58 RainDance Technologies, Inc. – Key Facts

TABLE 59 Dolomite Centre – Key Facts

TABLE 60 Micronit Microfluidics – Key Facts



TABLE 61 Johnson & Johnson – Key Facts

TABLE 62 Becton, Dickinson and Company – Key Facts

About Us

P&S Market Research is a global market research and consulting company. We provide market research reports,

industry reports, business intelligence and research based consulting services across a range of industries.

With the help of our professional corporate relations with various companies, our market research offers the most

accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned

domain to substantiate every single data presented in our publication. Our research assists our client in

identifying new and different windows of opportunity and frame informed and customized strategies for expansion

in different regions.

Contact: Ms Somya

347, 5th Ave. #1402

New York City, NY - 10016 Toll-free: +1-888-778-7886 (USA/Canada)

Email: [email protected]

Web: https://www.psmarketresearch.com

mailto:[email protected]

https://www.psmarketresearch.com/

Documents

Global Microfluidic Devices Market, Share, Size, Trend, Analysis and forecast to 2020